Development and use of FRAX in osteoporosis.
This paper reviews briefly the development and clinical use of FRAX in the development of assessment guidelines for osteoporosis.Fractures are the clinical consequence of osteoporosis and are a major cause of morbidity and mortality worldwide. Several treatments are available that have been shown to decrease the risk of fracture, but problems arise in identifying individuals at high fracture risk so that treatments can be effectively targeted. Case finding can be enhanced by the consideration of clinical risk factors that provide information on fracture risk over and above that provided by bone mineral density measurements. The FRAX tool integrates information on fracture risk from clinical risk factors with or without the use of BMD and can be used to improve the targeting of individuals at high fracture risk.
Kanis
J A
JA
WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK. w.j.pontefract@shef.ac.uk
McCloskey
E V
EV
Johansson
H
H
Oden
A
A
Ström
O
O
Borgström
F
F
D000368:Aged; D000465:Algorithms; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy; D058866:Osteoporotic Fractures / Q000209:etiology* / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D018570:Risk Assessment / Q000379:methods*; D016896:Treatment Outcome; D014944:World Health Organization
D050071:Bone Density Conservation Agents
J Bone Miner Res. 2002 Jul;17(7):1237-44
12096837
Osteoporos Int. 2005 Jul;16(7):737-42
15455194
Orthopade. 2007 Jul;36(7):683-90; quiz 691
17605128
Osteoporos Int. 2005 Mar;16(3):239-54
15726235
J Clin Densitom. 2007 Apr-Jun;10(2):120-3
17485028
Lancet. 2002 Jun 1;359(9321):1929-36
12057569
J Bone Miner Res. 2004 Jun;19(6):893-9
15125788
J Bone Miner Res. 2003 Jun;18(6):1139-41
12817771
Health Technol Assess. 2007 Mar;11(7):iii-iv, ix-xi, 1-231
17311734
Osteoporos Int. 2005 Jun;16(6):581-9
15616758
Rev Med Liege. 2009 Dec;64(12):612-9
20143744
Osteoporos Int. 2008 Oct;19(10):1395-408
18751937
Osteoporos Int. 2005 Feb;16(2):155-62
15175845
Osteoporos Int. 2008 Apr;19(4):449-58
18292975
J Clin Invest. 1988 Jun;81(6):1804-9
3384952
Bone. 2004 Nov;35(5):1029-37
15542027
Osteoporos Int. 2008 Apr;19(4):399-428
18266020
Osteoporos Int. 2005 Mar;16(3):229-38
15618996
Osteoporos Int. 2002 Jul;13(7):527-36
12111012
Osteoporos Int. 2009 Nov;20(11):1939-45
19326036
Bone. 2009 Jun;44(6):1049-54
19254788
Osteoporos Int. 2008 Apr;19(4):437-47
18292976
Osteoporos Int. 2000;11(8):669-74
11095169
Osteoporos Int. 2010 Mar;21(3):381-9
19517155
Bone. 2004 Aug;35(2):375-82
15268886
Osteoporos Int. 2008 Apr;19(4):429-35
18292977
Osteoporos Int. 2009 May;20(5):811-7
19002369
Ortop Traumatol Rehabil. 2007 Jul-Aug;9(4):337-56
17882114
Osteoporos Int. 2005 Nov;16(11):1330-8
15928804
Bone. 2008 Jan;42(1):4-15
18156107
Osteoporos Int. 2007 Aug;18(8):1033-46
17323110
Osteoporos Int. 2008 Apr;19(4):383-4
18297369
Osteoporos Int. 2001 Dec;12(12):989-95
11846333